{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:49:58Z","timestamp":1791978598829,"version":"4.4.0"},"reference-count":208,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.pharmthera.2012.06.007","type":"journal-article","created":{"date-parts":[[2012,6,30]],"date-time":"2012-06-30T00:31:06Z","timestamp":1341016266000},"page":"355-370","source":"Crossref","is-referenced-by-count":161,"title":["The sodium iodide symporter (NIS): Regulation and approaches to targeting for cancer therapeutics"],"prefix":"10.1016","volume":"135","author":[{"given":"Takahiko","family":"Kogai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Brent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2012.06.007_bb0005","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/cgt.2010.3","article-title":"Enhanced anti-tumor effects of combined MDR1 RNA interference and human sodium\/iodide symporter (NIS) radioiodine gene therapy using an adenoviral system in a colon cancer model","volume":"17","author":"Ahn","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0010","first-page":"1551","article-title":"Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma","volume":"39","author":"Alexander","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0015","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1093\/nar\/gkq023","article-title":"Intronic elements in the Na+\/I\u2212 symporter gene (NIS) interact with retinoic acid receptors and mediate initiation of transcription","volume":"38","author":"Alotaibi","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0020","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1074\/jbc.M007431200","article-title":"Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid","volume":"276","author":"Alsayed","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2407-7-5","article-title":"Expression of the Na+\/I\u2212 symporter (NIS) is markedly decreased or absent in gastric cancer and intestinal metaplastic mucosa of Barrett esophagus","volume":"7","author":"Altorjay","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0030","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1210\/jc.2004-1562","article-title":"Regulation of iodide uptake and sodium\/iodide symporter expression in the MCF-7 human breast cancer cell line","volume":"90","author":"Arturi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0035","doi-asserted-by":"crossref","first-page":"10454","DOI":"10.1128\/MCB.25.23.10454-10464.2005","article-title":"Generation and characterization of p38beta (MAPK11) gene-targeted mice","volume":"25","author":"Beardmore","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0040","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0140-6736(03)12720-1","article-title":"Sodium iodide symporter: a novel strategy to target breast, prostate, and other cancers?","volume":"361","author":"Boelaert","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0045","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1038\/sj.onc.1210221","article-title":"PTTG and PBF repress the human sodium iodide symporter","volume":"26","author":"Boelaert","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0050","first-page":"3484","article-title":"Adenovirus-mediated transfer of the thyroid sodium\/iodide symporter gene into tumors for a targeted radiotherapy","volume":"60","author":"Boland","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0055","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.72.121801.161800","article-title":"Signals for sorting of transmembrane proteins to endosomes and lysosomes","volume":"72","author":"Bonifacino","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0060","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-2672.2000.01098.x","article-title":"The lactoperoxidase system: the influence of iodide and the chemical and antimicrobial stability over the period of about 18 months","volume":"89","author":"Bosch","year":"2000","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0065","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1172\/JCI103155","article-title":"Observations on the mechanism of the renal clearance of I131","volume":"34","author":"Bricker","year":"1955","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1961.41.1.189","article-title":"Extrathyroidal iodide concentrating mechanisms","volume":"41","author":"Brown-Grant","year":"1961","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0075","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1089\/105072501300176408","article-title":"The toxicology of iodate: a review of the literature","volume":"11","author":"Burgi","year":"2001","journal-title":"Thyroid"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/me.2004-0093","article-title":"Thyroid hormone induces rapid activation of Akt\/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts","volume":"19","author":"Cao","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2214\/AJR.08.1205","article-title":"Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene","volume":"192","author":"Carlson","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0090","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1210\/jc.86.11.5627","article-title":"Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake","volume":"86","author":"Castro","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/thy.1997.7.177","article-title":"Iodine metabolism and thyroid physiology: current concepts","volume":"7","author":"Cavalieri","year":"1997","journal-title":"Thyroid"},{"issue":"Pt 1","key":"10.1016\/j.pharmthera.2012.06.007_bb0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1042\/bj3360223","article-title":"Recombinant human glutathione S-transferases catalyse enzymic isomerization of 13-cis-retinoic acid to all-trans-retinoic acid in vitro","volume":"336","author":"Chen","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.nucmedbio.2010.07.010","article-title":"Reduction of stimulated sodium iodide symporter expression by estrogen receptor ligands in breast cancer cells","volume":"38","author":"Cheong","year":"2011","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0110","first-page":"211","article-title":"Systemic pharmacokinetics of acitretin, etretinate, isotretinoin, and acetylenic retinoids in guinea pigs and obese rats","volume":"20","author":"Chien","year":"1992","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0115","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1210\/jc.85.8.2936","article-title":"Hormonal regulation of radioiodide uptake activity and Na+\/I\u2212 symporter expression in mammary glands","volume":"85","author":"Cho","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0120","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/me.2004-0020","article-title":"The CRE-like element inside the 5\u2032-upstream region of the rat sodium\/iodide symporter gene interacts with diverse classes of b-Zip molecules that regulate transcriptional activities through strong synergy with Pax-8","volume":"18","author":"Chun","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s002800050883","article-title":"Antitumor activity, distribution, and metabolism of 13-cis-retinoic acid as a single agent or in combination with tamoxifen in established human MCF-7 xenografts in mice","volume":"43","author":"Conley","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0130","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1074\/jbc.M307138200","article-title":"The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium\/iodide symporter gene","volume":"279","author":"Costamagna","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0135","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/379458a0","article-title":"Cloning and characterization of the thyroid iodide transporter","volume":"379","author":"Dai","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0140","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1165\/rcmb.2005-0306OC","article-title":"Retinoic acid inhibits airway smooth muscle cell migration","volume":"34","author":"Day","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1074\/jbc.M110.167197","article-title":"Surprising substrate versatility in SLC5A6: Na+\u2010coupled I\u2212 transport by the human Na+\/multivitamin transporter (hSMVT)","volume":"286","author":"de Carvalho","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1677\/JOE-09-0436","article-title":"MTOR downregulates iodide uptake in thyrocytes","volume":"206","author":"de Souza","year":"2010","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/343177a0","article-title":"Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene","volume":"343","author":"de The","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0160","first-page":"97","article-title":"Expression of the RET\/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factors","volume":"9","author":"De Vita","year":"1998","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0165","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1038\/sj.onc.1206485","article-title":"Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1\/PI 3-kinase\/AKT pathway","volume":"22","author":"del Rincon","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0170","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1182\/blood-2003-07-2233","article-title":"Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter","volume":"103","author":"Dingli","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0175","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1210\/jc.86.6.2697","article-title":"Rapid communication: predominant intracellular overexpression of the Na(+)\/I(\u2212) symporter (NIS) in a large sampling of thyroid cancer cases","volume":"86","author":"Dohan","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0185","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/er.2001-0029","article-title":"The sodium\/iodide symporter (NIS): characterization, regulation, and medical significance","volume":"24","author":"Dohan","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0180","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1210\/me.2005-0376","article-title":"Hydrocortisone and purinergic signaling stimulate sodium\/iodide symporter (NIS)-mediated iodide transport in breast cancer cells","volume":"20","author":"Dohan","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0190","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1210\/jc.2005-2838","article-title":"Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy","volume":"91","author":"Durante","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0200","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ymthe.2005.05.013","article-title":"A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer","volume":"12","author":"Dwyer","year":"2005","journal-title":"Mol Ther"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0195","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1089\/hum.2006.17.661","article-title":"Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors","volume":"17","author":"Dwyer","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0205","first-page":"4744","article-title":"Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms","volume":"54","author":"Fabbro","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0210","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1210\/jc.2004-1426","article-title":"Challenging dogma in thyroid cancer molecular genetics\u2014role of RET\/PTC and BRAF in tumor initiation","volume":"89","author":"Fagin","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0215","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1210\/en.2007-1390","article-title":"Identification of cyclic adenosine 3\u2032,5\u2032-monophosphate response element modulator as an activator of the human sodium\/iodide symporter upstream enhancer","volume":"149","author":"Fenton","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0220","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/thy.2010.0008","article-title":"Sunitinib inhibits MEK\/ERK and SAPK\/JNK pathways and increases sodium\/iodide symporter expression in papillary thyroid cancer","volume":"20","author":"Fenton","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0225","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1172\/JCI107430","article-title":"Demonstration of iodide transport defect but normal iodide organification in nonfunctioning nodules of human thyroid glands","volume":"52","author":"Field","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0230","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10549-010-0789-z","article-title":"The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS)","volume":"124","author":"Fortunati","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0235","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1677\/joe.1.06967","article-title":"Endogenous thyrocyte-produced nitric oxide inhibits iodide uptake and thyroid-specific gene expression in FRTL-5 thyroid cells","volume":"192","author":"Fozzatti","year":"2007","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0240","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-120-4-199402150-00004","article-title":"All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study","volume":"120","author":"Frankel","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0245","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00259-008-1024-6","article-title":"Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines","volume":"36","author":"Frohlich","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0250","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1210\/en.140.12.5705","article-title":"Estradiol increases proliferation and down-regulates the sodium\/iodide symporter gene in FRTL-5 cells","volume":"140","author":"Furlanetto","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0260","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1210\/en.2003-1258","article-title":"Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by expression of the sodium\/iodide symporter thyroperoxidase and thyroglobulin","volume":"145","author":"Furuya","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0255","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1073\/pnas.0510849103","article-title":"Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor","volume":"103","author":"Furuya","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0265","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/me.16.2.342","article-title":"PI3K is involved in the IGF-I inhibition of TSH-induced sodium\/iodide symporter gene expression","volume":"16","author":"Garcia","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0270","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1210\/jc.2003-030586","article-title":"Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas","volume":"88","author":"Gerard","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0275","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1182\/blood-2007-01-065573","article-title":"Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene","volume":"110","author":"Goel","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0280","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature02399","article-title":"The DNA sequence and biology of human chromosome 19","volume":"428","author":"Grimwood","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0285","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1158\/1078-0432.CCR-08-2571","article-title":"Targeted radiotherapy for prostate cancer with an oncolytic adenovirus coding for human sodium iodide symporter","volume":"15","author":"Hakkarainen","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0290","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/jnci\/djr373","article-title":"Thyroid dysfunction from antineoplastic agents","volume":"103","author":"Hamnvik","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0295","doi-asserted-by":"crossref","first-page":"33240","DOI":"10.1074\/jbc.M507617200","article-title":"Activation of peroxisome proliferator-activated receptor beta\/delta (PPARbeta\/delta) increases the expression of prostaglandin E2 receptor subtype EP4. The roles of phosphatidylinositol 3-kinase and CCAAT\/enhancer-binding protein beta","volume":"280","author":"Han","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0300","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0303-7207(99)00166-5","article-title":"Extracellular adenosine increases Na+\/I\u2212 symporter gene expression in rat thyroid FRTL-5 cells","volume":"157","author":"Harii","year":"1999","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0305","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1210\/me.2004-0100","article-title":"Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis","volume":"19","author":"Harii","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0310","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1210\/jc.84.11.3877","article-title":"A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer","volume":"84","author":"Haugen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0315","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1089\/hum.2007.153","article-title":"Internal radiotherapy of liver cancer with rat hepatocarcinoma\u2013intestine\u2013pancreas gene as a liver tumor-specific promoter","volume":"19","author":"Herve","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0320","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2174\/156800910791054194","article-title":"The biology of the sodium iodide symporter and its potential for targeted gene delivery","volume":"10","author":"Hingorani","year":"2010","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0325","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/mt.2010.120","article-title":"Therapeutic effect of sodium iodide symporter gene therapy combined with external beam radiotherapy and targeted drugs that inhibit DNA repair","volume":"18","author":"Hingorani","year":"2010","journal-title":"Mol Ther"},{"issue":"S1","key":"10.1016\/j.pharmthera.2012.06.007_bb0330","first-page":"A-111","article-title":"Reacquisition of RAI uptake in RAI-refractory metastatic thyroid cancers by pretreatment with the selective MEK inhibitor selumetinib","volume":"21","author":"Ho","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0335","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1210\/jc.2009-1888","article-title":"Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways","volume":"95","author":"Hou","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0340","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/bdd.2510150502","article-title":"Pharmacokinetics of a novel retinoid AGN 190168 and its metabolite AGN 190299 after intravenous administration of AGN 190168 to rats","volume":"15","author":"Hsyu","year":"1994","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0345","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/cgt.2010.66","article-title":"Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter","volume":"18","author":"Huang","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0350","doi-asserted-by":"crossref","first-page":"31491","DOI":"10.1074\/jbc.M205016200","article-title":"Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers","volume":"277","author":"Idres","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0360","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/ijc.22837","article-title":"Human sodium iodide symporter gene adjunctive radiotherapy to enhance the preventive effect of hMUC1 DNA vaccine","volume":"121","author":"Jeon","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0355","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1089\/cbr.2010.0837","article-title":"Human sodium iodide symporter added to multidrug resistance 1 small hairpin RNA in a single gene construct enhances the therapeutic effects of radioiodine in a nude mouse model of multidrug resistant colon cancer","volume":"25","author":"Jeon","year":"2010","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0365","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1089\/cbr.2011.1081","article-title":"Combined E7-dendritic cell-based immunotherapy and human sodium\/iodide symporter radioiodine gene therapy with monitoring of antitumor effects by bioluminescent imaging in a mouse model of uterine cervical cancer","volume":"26","author":"Jeon","year":"2011","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0370","doi-asserted-by":"crossref","first-page":"17920","DOI":"10.1074\/jbc.271.30.17920","article-title":"Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta)","volume":"271","author":"Jiang","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0380","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1365-201X.2002.00968.x","article-title":"Sodium\/iodide-symporter: distribution in different mammals and role in entero-thyroid circulation of iodide","volume":"175","author":"Josefsson","year":"2002","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0375","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/153537020623100306","article-title":"Sodium-iodide symporter mediates iodide secretion in rat gastric mucosa in vitro","volume":"231","author":"Josefsson","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0385","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.2967\/jnumed.108.055764","article-title":"Mitogen-activated protein kinase signaling enhances sodium iodide symporter function and efficacy of radioiodide therapy in nonthyroidal cancer cells","volume":"49","author":"Jung","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0390","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2174\/0929867024606975","article-title":"Novel synthetic retinoids and separation of the pleiotropic retinoidal activities","volume":"9","author":"Kagechika","year":"2002","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0395","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1210\/me.10.7.801","article-title":"Redox regulation of thyroid-transcription factors, Pax-8 and TTF-1, is involved in their increased DNA-binding activities by thyrotropin in rat thyroid FRTL-5 cells","volume":"10","author":"Kambe","year":"1996","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0400","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/thy.1997.7.789","article-title":"Transforming growth factor-beta1 suppresses thyrotropin-induced Na+\/I\u2212 symporter messenger RNA and protein levels in FRTL-5 rat thyroid cells","volume":"7","author":"Kawaguchi","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0405","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1158\/1078-0432.CCR-08-2743","article-title":"Targeting vascular endothelial growth factor receptor in thyroid cancer: the intracellular and extracellular implications","volume":"16","author":"Keefe","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0410","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.4161\/cbt.6.7.4342","article-title":"In vivo long-term imaging and radioiodine therapy by sodium-iodide symporter gene expression using a lentiviral system containing ubiquitin C promoter","volume":"6","author":"Kim","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0415","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.2967\/jnumed.111.090266","article-title":"Combined RNA interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic thyroid carcinoma","volume":"52","author":"Kim","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0425","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1089\/hum.2008.030","article-title":"Tumor-targeted radionuclide imaging and therapy based on human sodium iodide symporter gene driven by a modified telomerase reverse transcriptase promoter","volume":"19","author":"Kim","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0420","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/cgt.2011.88","article-title":"Complementary treatment of siTERT for improving the antitumor effect of TERT-specific I-131 therapy","volume":"19","author":"Kim","year":"2012","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0430","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1210\/jc.86.7.3430","article-title":"Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)\/I(\u2212) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells","volume":"86","author":"Kitazono","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0435","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1158\/1078-0432.CCR-09-0851","article-title":"Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene","volume":"15","author":"Klutz","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0440","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1089\/hum.2011.041","article-title":"Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene","volume":"22","author":"Klutz","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0445","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/mt.2011.93","article-title":"Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene delivery","volume":"19","author":"Knoop","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0450","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2407-7-137","article-title":"PI3K activation is associated with intracellular sodium\/iodide symporter protein expression in breast cancer","volume":"7","author":"Knostman","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0460","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1210\/en.138.6.2227","article-title":"Regulation by thyroid-stimulating hormone of sodium\/iodide symporter gene expression and protein levels in FRTL-5 cells","volume":"138","author":"Kogai","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0455","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/joe.0.1670125","article-title":"Induction of follicle formation in long-term cultured normal human thyroid cells treated with thyrotropin stimulates iodide uptake but not sodium\/iodide symporter messenger RNA and protein expression","volume":"167","author":"Kogai","year":"2000","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0495","doi-asserted-by":"crossref","first-page":"8519","DOI":"10.1073\/pnas.140217197","article-title":"Retinoic acid induces sodium\/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line","volume":"97","author":"Kogai","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0465","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1210\/en.142.8.3369","article-title":"Differential regulation of the human sodium\/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells","volume":"142","author":"Kogai","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0470","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1158\/0008-5472.CAN-03-2285","article-title":"Systemic retinoic acid treatment induces sodium\/iodide symporter expression and radioiodide uptake in mouse breast cancer models","volume":"64","author":"Kogai","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0475","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1210\/en.2004-1334","article-title":"Differential regulation of sodium\/iodide symporter gene expression by nuclear receptor ligands in MCF-7 breast cancer cells","volume":"146","author":"Kogai","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0500","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1677\/erc.1.01143","article-title":"Enhancement of sodium\/iodide symporter expression in thyroid and breast cancer","volume":"13","author":"Kogai","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0485","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1210\/jc.2007-1627","article-title":"Retinoic acid stimulation of the sodium\/iodide symporter in MCF-7 breast cancer cells is mediated by the insulin growth factor-I\/phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways","volume":"93","author":"Kogai","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0490","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1677\/JOE-08-0333","article-title":"Phosphoinositide-3-kinase inhibition induces sodium\/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells","volume":"199","author":"Kogai","year":"2008","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0480","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1074\/jbc.M111.315523","article-title":"Regulation of sodium iodide symporter gene expression by the Rac1\/p38beta MAP kinase signaling pathway in MCF-7 breast cancer cells","volume":"287","author":"Kogai","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0505","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/B:BREA.0000014042.54925.cc","article-title":"Relevance of breast cancer cell lines as models for breast tumours: an update","volume":"83","author":"Lacroix","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0510","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJM199709253371304","article-title":"Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma","volume":"337","author":"Ladenson","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0515","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2164-8-23","article-title":"Widespread Alu repeat-driven expansion of consensus DR2 retinoic acid response elements during primate evolution","volume":"8","author":"Laperriere","year":"2007","journal-title":"BMC Genomics"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0520","doi-asserted-by":"crossref","first-page":"22657","DOI":"10.1074\/jbc.273.35.22657","article-title":"N-linked glycosylation of the thyroid Na+\/I\u2212 symporter (NIS). Implications for its secondary structure model","volume":"273","author":"Levy","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0525","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/cgt.2010.10","article-title":"Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy","volume":"17","author":"Li","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0530","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.1210\/jc.2005-0079","article-title":"Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3\u2032-kinase-dependent pathway","volume":"90","author":"Lin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0535","first-page":"241","article-title":"Susceptibility of Candida albicans to peroxidase-catalyzed oxidation products of thiocyanate, iodide and bromide","volume":"20","author":"Majerus","year":"1992","journal-title":"J Biol Buccale"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0540","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0545","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1210\/jc.2007-0586","article-title":"A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake","volume":"92","author":"Mannavola","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0550","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ng0598-87","article-title":"Follicular cells of the thyroid gland require Pax8 gene function","volume":"19","author":"Mansouri","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0555","first-page":"1089","article-title":"Prolonged iodine clearance with a depletion regimen for thyroid carcinoma: concise communication","volume":"25","author":"Maruca","year":"1984","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0560","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1210\/me.2007-0062","article-title":"Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor","volume":"21","author":"Masia","year":"2007","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0565","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0889-8529(18)30317-7","article-title":"Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer","volume":"19","author":"Maxon","year":"1990","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0570","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJM198310203091601","article-title":"Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer","volume":"309","author":"Maxon","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0575","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0960-0760(97)00033-2","article-title":"Trans-retinoic acid and glucocorticoids synergistically induce transcription from the mouse mammary tumor virus promoter in human embryonic kidney cells","volume":"62","author":"Medh","year":"1997","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0580","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1210\/jc.78.1.188","article-title":"Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I\/II study)","volume":"78","author":"Meier","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0585","first-page":"1065","article-title":"rhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of (131)I","volume":"44","author":"Menzel","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0590","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3168\/jds.S0022-0302(75)84753-9","article-title":"Iodine absorption, excretion, recycling, and tissue distribution in the dairy cow","volume":"58","author":"Miller","year":"1975","journal-title":"J Dairy Sci"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0595","first-page":"857","article-title":"Summary of current radiation dose estimates to humans from 123I, 124I, 125I, 126I, 130I, 131I, and 132I as sodium iodide","volume":"16","author":"MIRD","year":"1975","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0600","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1210\/en.2005-0280","article-title":"BRAF mediates RET\/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET\/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis","volume":"147","author":"Mitsutake","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0605","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1210\/jc.79.2.616","article-title":"Immunohistochemical demonstration of thyrotropin (TSH)-receptor in normal and diseased human thyroid tissues using monoclonal antibody against recombinant human TSH-receptor protein","volume":"79","author":"Mizukami","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0610","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/cgt.2008.6","article-title":"Targeting sodium\/iodide symporter gene expression for estrogen-regulated imaging and therapy in breast cancer","volume":"15","author":"Montiel-Equihua","year":"2008","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0615","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0969-8051(01)00243-8","article-title":"Correlation between 99mTc-pertechnetate uptakes and expressions of human sodium iodide symporter gene in breast tumor tissues","volume":"28","author":"Moon","year":"2001","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0620","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2174\/1381612003400146","article-title":"Recent developments in receptor-selective retinoids","volume":"6","author":"Nagpal","year":"2000","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0625","doi-asserted-by":"crossref","first-page":"C654","DOI":"10.1152\/ajpcell.00509.2008","article-title":"The Na+\/I\u2212 symporter mediates active iodide uptake in the intestine","volume":"296","author":"Nicola","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0635","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1210\/en.2008-0345","article-title":"Functional toll-like receptor 4 conferring lipopolysaccharide responsiveness is expressed in thyroid cells","volume":"150","author":"Nicola","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0630","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1210\/me.2010-0102","article-title":"NF-kappaB p65 subunit mediates lipopolysaccharide-induced Na(+)\/I(\u2212) symporter gene expression by involving functional interaction with the paired domain transcription factor Pax8","volume":"24","author":"Nicola","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0640","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1158\/0008-5472.CAN-07-0823","article-title":"Down-regulation of the sodium\/iodide symporter explains 131I-induced thyroid stunning","volume":"67","author":"Norden","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0645","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1158\/0008-5472.CAN-08-3234","article-title":"Activation of the PI3 kinase pathway by retinoic acid mediates sodium\/iodide symporter induction and iodide transport in MCF-7 breast cancer cells","volume":"69","author":"Ohashi","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0650","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1128\/MCB.19.3.2051","article-title":"The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium\/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription","volume":"19","author":"Ohno","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0655","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/0006-291X(91)91540-S","article-title":"The mRNA levels of thyrotropin receptor, thyroglobulin and thyroid peroxidase in neoplastic human thyroid tissues","volume":"174","author":"Ohta","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0660","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1210\/jc.82.8.2633","article-title":"Growth inhibition of new human thyroid carcinoma cell lines by activation of adenylate cyclase through the beta-adrenergic receptor","volume":"82","author":"Ohta","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0665","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1258\/ebm.2009.009241","article-title":"Dual oxidase, hydrogen peroxide and thyroid diseases","volume":"235","author":"Ohye","year":"2010","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0670","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/en.131.1.45","article-title":"Transforming growth factor-beta blocks protein kinase-A-mediated iodide transport and protein kinase-C-mediated DNA synthesis in FRTL-5 rat thyroid cells","volume":"131","author":"Pang","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0675","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1089\/thy.2005.15.222","article-title":"Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines","volume":"15","author":"Park","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0680","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1158\/1078-0432.CCR-09-0262","article-title":"Targeted radionuclide therapy using a Wnt-targeted replicating adenovirus encoding the Na\/I symporter","volume":"15","author":"Peerlinck","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0685","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1210\/me.11.4.433","article-title":"Isolation and characterization of a pituitary tumor-transforming gene (PTTG)","volume":"11","author":"Pei","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0690","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1210\/en.139.2.703","article-title":"Tumor necrosis factor, ceramide, transforming growth factor-beta1, and aging reduce Na+\/I\u2212 symporter messenger ribonucleic acid levels in FRTL-5 cells","volume":"139","author":"Pekary","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0695","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1210\/en.2011-1548","article-title":"TSH regulates pendrin membrane abundance and enhances iodide efflux in thyroid cells","volume":"153","author":"Pesce","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0700","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1089\/thy.2007.0303","article-title":"Role of transforming growth factor beta in the regulation of thyroid function and growth","volume":"19","author":"Pisarev","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0705","doi-asserted-by":"crossref","first-page":"40539","DOI":"10.1074\/jbc.M002097200","article-title":"Thyroid-stimulating hormone and cyclic AMP activate p38 mitogen-activated protein kinase cascade. Involvement of protein kinase A, rac1, and reactive oxygen species","volume":"275","author":"Pomerance","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0710","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1074\/jbc.M207732200","article-title":"p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity","volume":"278","author":"Pramanik","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0715","first-page":"311","article-title":"Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases","volume":"20","author":"Puglisi","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0720","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1210\/en.2003-1250","article-title":"Transcriptional regulation of human sodium\/iodide symporter gene: a role for redox factor-1","volume":"145","author":"Puppin","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0725","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1158\/0008-5472.CAN-11-0720","article-title":"Proto-oncogene PBF\/PTTG1IP regulates thyroid cell growth and represses radioiodide treatment","volume":"71","author":"Read","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0730","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1158\/0008-5472.CAN-09-0727","article-title":"Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1","volume":"69","author":"Ricarte-Filho","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0735","doi-asserted-by":"crossref","first-page":"21458","DOI":"10.1074\/jbc.M100561200","article-title":"Post-transcriptional regulation of the sodium\/iodide symporter by thyrotropin","volume":"276","author":"Riedel","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0750","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/eje.1.02257","article-title":"A perspective view of sodium iodide symporter research and its clinical implications","volume":"155","author":"Riesco-Eizaguirre","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0745","doi-asserted-by":"crossref","first-page":"8317","DOI":"10.1158\/0008-5472.CAN-09-1248","article-title":"The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer","volume":"69","author":"Riesco-Eizaguirre","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0740","doi-asserted-by":"crossref","first-page":"E1435","DOI":"10.1210\/jc.2010-2373","article-title":"Telomerase-driven expression of the sodium iodide symporter (NIS) for in vivo radioiodide treatment of cancer: a new broad-spectrum NIS-mediated antitumor approach","volume":"96","author":"Riesco-Eizaguirre","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0755","first-page":"284","article-title":"Quantitative aspects of iodine metabolism in man","volume":"4","author":"Riggs","year":"1952","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0760","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1210\/jc.2005-2532","article-title":"Prognostic significance of human pituitary tumor-transforming gene immunohistochemical expression in differentiated thyroid cancer","volume":"91","author":"Saez","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0770","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1210\/jc.82.10.3331","article-title":"Increased expression of the Na+\/I\u2212 symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue","volume":"82","author":"Saito","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0765","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI1259","article-title":"Increased expression of the sodium\/iodide symporter in papillary thyroid carcinomas","volume":"101","author":"Saito","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0775","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1210\/endo-127-4-1867","article-title":"Effect of hydrocortisone on the ability of thyrotropin to increase deoxyribonucleic acid synthesis and iodide uptake in FRTL-5 rat thyroid cells: opposite regulation of adenosine 3\u2032,5\u2032-monophosphate signal action","volume":"127","author":"Saji","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0780","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1210\/endo-128-2-1136","article-title":"Insulin and insulin-like growth factor-I inhibit thyrotropin-increased iodide transport in serum-depleted FRTL-5 rat thyroid cells: modulation of adenosine 3\u2032,5\u2032-monophosphate signal action","volume":"128","author":"Saji","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0785","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1089\/thy.2007.0336","article-title":"Effect of sunitinib on growth and function of FRTL-5 thyroid cells","volume":"18","author":"Salem","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0790","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jc.2003-031167","article-title":"Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer","volume":"89","author":"Sawka","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0795","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM199801293380506","article-title":"Papillary and follicular thyroid carcinoma","volume":"338","author":"Schlumberger","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0800","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ncpendmet0449","article-title":"Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients","volume":"3","author":"Schlumberger","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0805","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/thy.2000.10.393","article-title":"Retinoic acid redifferentiation therapy for thyroid cancer","volume":"10","author":"Schmutzler","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0810","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1006\/bbrc.1997.7715","article-title":"Retinoic acid increases sodium\/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells","volume":"240","author":"Schmutzler","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0815","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1210\/jc.2008-1102","article-title":"Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification","volume":"93","author":"Schweppe","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0820","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/thy.2009.0171","article-title":"Resveratrol increases iodide trapping in the rat thyroid cell line FRTL-5","volume":"20","author":"Sebai","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0825","first-page":"2223","article-title":"Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice","volume":"43","author":"Seibert","year":"1983","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0830","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1753-4887.2001.tb05512.x","article-title":"Iodine in human milk: perspectives for infant health","volume":"59","author":"Semba","year":"2001","journal-title":"Nutr Rev"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0835","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.gt.3302147","article-title":"Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy","volume":"11","author":"Shen","year":"2004","journal-title":"Gene Ther"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0840","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1210\/en.138.10.4493","article-title":"Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+\/I\u2212 symporter gene","volume":"138","author":"Shimura","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0845","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/en.2006-0937","article-title":"AKT in thyroid tumorigenesis and progression","volume":"148","author":"Shinohara","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0850","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1210\/en.138.8.3555","article-title":"Expression, exon\u2013intron organization, and chromosome mapping of the human sodium iodide symporter","volume":"138","author":"Smanik","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0855","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1242\/jcs.045427","article-title":"A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer","volume":"122","author":"Smith","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0870","first-page":"6526","article-title":"Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter","volume":"60","author":"Spitzweg","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0865","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/sj.gt.3301558","article-title":"In vivo sodium iodide symporter gene therapy of prostate cancer","volume":"8","author":"Spitzweg","year":"2001","journal-title":"Gene Ther"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0860","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1089\/hum.2007.081","article-title":"Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression","volume":"18","author":"Spitzweg","year":"2007","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0875","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF03346542","article-title":"Regulation of sodium\/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines","volume":"33","author":"Sponziello","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0880","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1210\/jc.2005-0523","article-title":"Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis","volume":"90","author":"Stratford","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0885","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/thy.1992.2.193","article-title":"Peroxidase and coupling activities of thyroid peroxidase in benign and malignant thyroid tumor tissues","volume":"2","author":"Takamatsu","year":"1992","journal-title":"Thyroid"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0890","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1210\/me.2002-0109","volume":"16","author":"Taki","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0895","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1023\/A:1024064424855","article-title":"Effect of ligands of nuclear hormone receptors on sodium\/iodide symporter expression and activity in breast cancer cells","volume":"79","author":"Tanosaki","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0900","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/78630","article-title":"The mammary gland iodide transporter is expressed during lactation and in breast cancer","volume":"6","author":"Tazebay","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0905","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/bbrc.1998.9548","article-title":"Ref-1 controls pax-8 DNA-binding activity","volume":"252","author":"Tell","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0910","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1210\/me.8.7.870","article-title":"Sensitive and specific detection of retinoid receptor subtype proteins in cultured cell and tumor extracts","volume":"8","author":"Titcomb","year":"1994","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0915","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1677\/JME-08-0176","article-title":"Transcriptional targets for pituitary tumor-transforming gene-1","volume":"43","author":"Tong","year":"2009","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0920","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/eje.0.1400447","article-title":"Iodide symporter gene expression in normal and transformed rat thyroid cells","volume":"140","author":"Trapasso","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0925","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/gt.2010.63","article-title":"A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer","volume":"17","author":"Trujillo","year":"2010","journal-title":"Gene Ther"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0930","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1046\/j.1432-1327.2000.01100.x","article-title":"Expression and regulation of alkaline phosphatases in human breast cancer MCF-7 cells","volume":"267","author":"Tsai","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0935","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1210\/jc.2005-0779","article-title":"Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells","volume":"91","author":"Unterholzner","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0940","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1677\/erc.1.01263","article-title":"MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner","volume":"14","author":"Vadysirisack","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0945","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1210\/jcem-26-12-1317","article-title":"Metastatic thyroid carcinoma in man concentrating iodine without organification","volume":"26","author":"Valenta","year":"1966","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0950","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1089\/thy.2009.1611","article-title":"The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer","volume":"19","author":"Van Nostrand","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0955","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.1210\/jc.2004-1414","article-title":"Forskolin, 8-Br-3\u2032,5\u2032-cyclic adenosine 5\u2032-monophosphate, and catalytic protein kinase A expression in the nucleus increase radioiodide uptake and sodium\/iodide symporter protein levels in RET\/PTC1-expressing cells","volume":"89","author":"Venkateswaran","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0960","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1210\/jc.2009-1233","article-title":"RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact","volume":"94","author":"Volante","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0965","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","article-title":"Signal integration by JNK and p38 MAPK pathways in cancer development","volume":"9","author":"Wagner","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0975","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1210\/jc.2002-021544","article-title":"Immunohistochemical profile of the sodium\/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections","volume":"88","author":"Wapnir","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0970","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1158\/1078-0432.CCR-04-0074","article-title":"The Na+\/I\u2212 symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid","volume":"10","author":"Wapnir","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0980","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3835(03)00392-6","article-title":"Low expression of sodium iodide symporter identifies aggressive thyroid tumors","volume":"200","author":"Ward","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0985","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1182\/blood.V82.7.1949.1949","article-title":"Retinoid resistance in acute promyelocytic leukemia: new mechanisms, strategies, and implications","volume":"82","author":"Warrell","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0990","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1158\/0008-5472.CAN-09-3531","article-title":"Pituitary tumor transforming gene binding factor: a new gene in breast cancer","volume":"70","author":"Watkins","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb0995","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2008.08.008","article-title":"PPARgamma-independent antitumor effects of thiazolidinediones","volume":"276","author":"Wei","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb1000","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1210\/endo-114-4-1090","article-title":"Iodide transport in a continuous line of cultured cells from rat thyroid","volume":"114","author":"Weiss","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb1005","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/35021173","article-title":"Taking up iodide in breast tissue","volume":"406","author":"Welcsh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb1015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/sj.gt.3303057","article-title":"Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma","volume":"15","author":"Willhauck","year":"2008","journal-title":"Gene Ther"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb1020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-007-9646-0","article-title":"Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone","volume":"109","author":"Willhauck","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb1010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10549-010-0835-x","article-title":"Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of (1)(3)(1)I by carbamazepine in breast cancer cells","volume":"125","author":"Willhauck","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb1025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/endo-64-1-1","article-title":"Iodide trapping without organification in a transplantable rat thyroid tumor","volume":"64","author":"Wolff","year":"1959","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb1030","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1210\/en.2006-1638","article-title":"Suppression of iodide uptake and thyroid hormone synthesis with stimulation of the type I interferon system by double-stranded ribonucleic acid in cultured human thyroid follicles","volume":"148","author":"Yamazaki","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb1035","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1152\/physrev.2001.81.3.1097","article-title":"Physiological and molecular basis of thyroid hormone action","volume":"81","author":"Yen","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2012.06.007_bb1040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/cbr.2008.0555","article-title":"Effects of theophylline on radioiodide uptake in MCF-7 breast cancer and NIS gene-transduced SNU-C5 colon cancer cells","volume":"24","author":"Yoon","year":"2009","journal-title":"Cancer Biother Radiopharm"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812001258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812001258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T03:52:26Z","timestamp":1594353146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725812001258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":208,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0163725812001258"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2012.06.007","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}